Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features

Molecular Psychiatry

Volumn 21, Issue 11, 2016, Pages 1599-1607

  Heidari, M ^a   Johnstone, D M ^b   Bassett, B ^a   Graham, R M ^c   Chua, A C G ^d,e   House, M J ^f   Collingwood, J F ^g   Bettencourt, C ^h   Houlden, H ^h   Ryten, M ^h,i   Olynyk, J K ^c,f,j,k   Trinder, D ^d,e   Milward, E A ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g UNIVERSITY OF WARWICK   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j MURDOCH UNIVERSITY   (Australia)

^k FREMANTLE HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE TYPE 13A2; CERULOPLASMIN; FATTY ACID 2 HYDROXYLASE; FERRITIN; IRON; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN; OXYGENASE; PANTOTHENATE KINASE 2; PHOSPHOLIPASE A2 GROUP VI; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG; HEMOCHROMATOSIS PROTEIN; MEMBRANE PROTEIN; TRANSFERRIN RECEPTOR; TRFR2 PROTEIN, MOUSE;

AGED; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; AUTOPSY; BASAL GANGLION; BRAIN HOMOGENATE; CHROMOSOME 19; COGNITION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HEMOCHROMATOSIS GENE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IRON STORAGE; MALE; MOUSE; MOUSE MODEL; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROPATHOLOGY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TRANSFERRIN RECEPTOR 2 GENE; TRANSMISSION ELECTRON MICROSCOPY; VERY ELDERLY; AKR MOUSE; ANIMAL; BLOOD; BRAIN; GENETICS; HEMOCHROMATOSIS; IRON METABOLISM DISORDER; METABOLISM; MYELIN SHEATH; NEUROAXONAL DYSTROPHY; PATHOPHYSIOLOGY; PEDIGREE; PHYSIOLOGY;

ANIMALS; BRAIN; GENE EXPRESSION; HEMOCHROMATOSIS; HEMOCHROMATOSIS PROTEIN; IRON; IRON METABOLISM DISORDERS; MEMBRANE PROTEINS; MICE; MICE, INBRED AKR; MYELIN SHEATH; NEUROAXONAL DYSTROPHIES; PEDIGREE; RECEPTORS, TRANSFERRIN;

EID: 84953279157     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.192     Document Type: Article

References (74)

1. Reynolds A, Krebs NF, Stewart PA, Austin H, Johnson SL, Withrow N et al. Iron status in children with autism spectrum disorder. Pediatrics 2012; 130 (Suppl 2): S154-S159.
2. Feifel D, Young CW. Iron overload among a psychiatric outpatient population. J Clin Psychiatry 1997; 58: 74-78.
3. Pecorelli A, Leoncini S, De Felice C, Signorini C, Cerrone C, Valacchi G et al. Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism. Brain Dev 2013; 35: 146-154.
4. Johnstone D, Milward EA. Molecular genetic approaches to understanding the roles and regulation of iron in brain health and disease. J Neurochem 2010; 113: 1387-1402.
5. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 2014; 13: 1045-1060.
6. Meyer E, Kurian MA, Hayflick SJ. Neurodegeneration with brain iron accumulation: genetic diversity and pathophysiological mechanisms. Annu Rev Genomics Hum Genet 2015; 16: 257-279.
7. Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis 2012; 46: 1-18.
8. Paisan-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E et al. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 2010; 25: 1791-1800.
9. Hogarth P. Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord 2015; 8: 1-13.
10. Serata D, Del Casale A, Rapinesi C, Mancinelli I, Pompili P, Kotzalidis GD et al. Hemochromatosis-induced bipolar disorder: a case report. Gen Hosp Psychiatry 2012; 34: 101 e101-101 e103.
11. Johnstone D, Graham RM, Trinder D, Delima RD, Riveros C, Olynyk JK et al. Brain transcriptome perturbations in the Hfe(-/-) mouse model of genetic iron loading. Brain Res 2012; 1448: 144-152.
12. Acikyol B, Graham RM, Trinder D, House MJ, Olynyk JK, Scott RJ et al. Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience 2013; 235: 119-128.
13. Golub MS, Germann SL, Araiza RS, Reader JR, Griffey SM, Lloyd KC. Movement disorders in the Hfe knockout mouse. Nutr Neurosci 2005; 8: 239-244.
14. Nandar W, Neely EB, Unger E, Connor JR. A mutation in the HFE gene is associated with altered brain iron profiles and increased oxidative stress in mice. Biochim Biophys Acta 2013; 1832: 729-741.
15. Delima RD, Chua AC, Tirnitz-Parker JE, Gan EK, Croft KD, Graham RM et al. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice. Hepatology 2012; 56: 585-593.
16. Del-Castillo-Rueda A, Moreno-Carralero MI, Cuadrado-Grande N, Alvarez-Sala-Walther LA, Enriquez-de-Salamanca R, Mendez M et al. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Gene 2012; 508: 15-20.
17. Mendes AI, Ferro A, Martins R, Picanco I, Gomes S, Cerqueira R et al. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes. Ann Hematol 2009; 88: 229-234.
18. Rueda Adel C, Grande NC, Fernandez EA, Enriquez de Salamanca R, Sala LA, Jimenez MJ. Mutations in HFE and TFR2 genes in a Spanish patient with hemo-chromatosis. Rev Esp Enferm Dig 2011; 103: 379-382.
19. Pietrangelo A, Caleffi A, Henrion J, Ferrara F, Corradini E, Kulaksiz H et al. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 2005; 128: 470-479.
20. Johnstone D, Milward EA. Genome-wide microarray analysis of brain gene expression in mice on a short-term high iron diet. Neurochem Int 2010; 56: 856-863.
21. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746-4751.
22. Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley KC. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res 2007; 151: 179-188.
23. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492-2497.
24. Fleming RE, Ahmann JR, Migas MC, Waheed A, Koeffler HP, Kawabata H et al. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci USA 2002; 99: 10653-10658.
25. Fleming RE, Holden CC, Tomatsu S, Waheed A, Brunt EM, Britton RS et al. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci USA 2001; 98: 2707-2711.
26. McLachlan S, Lee SM, Steele TM, Hawthorne PL, Zapala MA, Eskin E et al. In silico QTL mapping of basal liver iron levels in inbred mouse strains. Physiol Genomics 2011; 43: 136-147.
27. Bender R, Lange S. Adjusting for multiple testing - when and how? J Clin Epidemiol 2001; 54: 343-349.
28. Johnstone D, Riveros C, Heidari M, Graham R, Trinder D, Berretta R et al. Evaluation of different normalization and analysis procedures for Illumina gene expression microarray data involving small changes. Microarrays 2013; 2: 131-152.
29. Bettencourt C, Ryten M, Wiethoff S, Forabosco P, Hardy J, Houlden H. Neurode-generation with Brain Iron Accumulation (NBIA): Insights from Gene Co-Expression Networks. In Walker R (ed). Proceedings of the Third Joint Symposium on Neuroacanthocytosis and Neurodegeneration with Brain Iron Accumulation: From Benchside to Bedside. Tremor Other Hyperkinet Mov (N Y). 2014; 4: 289.
30. Meguro R, Asano Y, Odagiri S, Li C, Iwatsuki H, Shoumura K. Nonheme-iron his-tochemistry for light and electron microscopy: a historical, theoretical and technical review. Arch Histol Cytol 2007; 70: 1-19.
31. Donovan V, Kim C, Anugerah AK, Coats JS, Oyoyo U, Pardo AC et al. Repeated mild traumatic brain injury results in long-term white-matter disruption. J Cereb Blood Flow Metab 2014; 34: 715-723.
32. Saadoun S, Tait MJ, Reza A, Davies DC, Bell BA, Verkman AS et al. AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology. Neuroscience 2009; 161: 764-772.
33. Xing YL, Roth PT, Stratton JA, Chuang BH, Danne J, Ellis SL et al. Adult neural precursor cells from the subventricular zone contribute significantly to oligo-dendrocyte regeneration and remyelination. J Neurosci 2014; 34: 14128-14146.
34. Mechan AO, Wyss A, Rieger H, Mohajeri MH. A comparison of learning and memory characteristics of young and middle-aged wild-type mice in the IntelliCage. J Neurosci Methods 2009; 180: 43-51.
35. Morgan NV, Westaway SK, Morton JEV, Gregory A, Gissen P, Sonek S et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 2006; 38: 752-754.
36. Evstatiev R, Gasche C. Iron sensing and signalling. Gut 2012; 61: 933-952.
37. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002; 22: 439-458.
38. Illingworth MA, Meyer E, Chong WK, Manzur AY, Carr LJ, Younis R et al. PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease. Mol Genet Metab 2014; 112: 183-189.
39. Kruer MC, Boddaert N, Schneider SA, Houlden H, Bhatia KP, Gregory A et al. Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol 2012; 33: 407-414.
40. Kruer MC, Paisan-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A et al. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 2010; 68: 611-618.
41. Hartig MB, Iuso A, Haack T, Kmiec T, Jurkiewicz E, Heim K et al. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet 2011; 89: 543-550.
42. Engel LA, Jing Z, O'Brien DE, Sun M, Kotzbauer PT. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One 2010; 5: e12897.
43. Eckhardt M, Yaghootfam A, Fewou SN, Zoller I, Gieselmann V. A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galacto-sylceramide in myelin. Biochem J 2005; 388: 245-254.
44. Espinosa de los Monteros A, Kumar S, Zhao P, Huang CJ, Nazarian R, Pan T et al. Transferrin is an essential factor for myelination. Neurochem Res 1999; 24: 235-248.
45. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996; 1275: 161-203.
46. Hama H. Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta 2010; 1801: 405-414.
47. Mancuso M, Davidzon G, Kurlan RM, Tawil R, Bonilla E, Di Mauro S et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol 2005; 64: 280-294.
48. Malik I, Turk J, Mancuso DJ, Montier L, Wohltmann M, Wozniak DF et al. Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am J Pathol 2008; 172: 406-416.
49. Chang YZ, Qian ZM, Wang K, Zhu L, Yang XD, Du JR et al. Effects of development and iron status on ceruloplasmin expression in rat brain. J Cell Physiol 2005; 204: 623-631.
50. McCarthy RC, Kosman DJ. Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells. PLoS One 2014; 9: e89003.
51. Jeong SY, David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 2003; 278: 27144-27148.
52. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958; 3: 41-51.
53. Paisan-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 2012; 33: 814-823.
54. Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol 2009; 65: 19-23.
55. Hall SM. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 1972; 10: 535-546.
56. Fujita R, Kiguchi N, Ueda H. LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem Int 2007; 50: 351-355.
57. Takeda M, Soliven B. Arachidonic acid inhibits myelin basic protein phosphor-ylation in cultured oligodendrocytes. Glia 1997; 21: 277-284.
58. Maldonado EN, Alderson NL, Monje PV, Wood PM, Hama H. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin. J Lipid Res 2008; 49: 153-161.
59. Zoller I, Meixner M, Hartmann D, Bussow H, Meyer R, Gieselmann V et al. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J Neurosci 2008; 28: 9741-9754.
60. Horvath R. Brain iron takes off: a new propeller protein links neurodegeneration with autophagy. Brain 2013; 136: 1687-1691.
61. van Veen S, Sorensen DM, Holemans T, Holen HW, Palmgren MG, Vangheluwe P. Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders. Front Mol Neurosci 2014; 7: 48.
62. Rinaldi DE, Corradi GR, Cuesta LM, Adamo HP, de Tezanos Pinto F. The Parkinson-associated human P-ATPase ATP13A2 protects against the iron-induced cyto-toxicity. Biochim Biophys Acta 2015; 1848: 1646-1655.
63. Rathore GS, Schaaf CP, Stocco AJ. Novel mutation of the WDR45 gene causing beta-propeller protein-associated neurodegeneration. Mov Disord 2014; 29: 574-575.
64. Okamoto N, Ikeda T, Hasegawa T, Yamamoto Y, Kawato K, Komoto T et al. Early manifestations of BPAN in a pediatric patient. Am J Med Genet A 2014; 164A: 3095-3099.
65. Ben-Omran T, Ali R, Almureikhi M, Alameer S, Al-Saffar M, Walsh CA et al. Phenotypic heterogeneity in Woodhouse-Sakati syndrome: two new families with a mutation in the C2orf37 gene. Am J Med Genet A 2011; 155A: 2647-2653.
66. Alazami AM, Schneider SA, Bonneau D, Pasquier L, Carecchio M, Kojovic M et al. C2orf37 mutational spectrum in Woodhouse-Sakati syndrome patients. Clin Genet 2010; 78: 585-590.
67. Abiko Y. Investigations on pantothenic acid and its related compounds. IX. Biochemical studies.4. Separation and substrate specificity of pantothenate kinase and phosphopantothenoylcysteine synthetase. J Biochem 1967; 61: 290-299.
68. Kruer MC, Hiken M, Gregory A, Malandrini A, Clark D, Hogarth P et al. Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration. Brain 2011; 134: 947-958.
69. Brunetti D, Dusi S, Morbin M, Uggetti A, Moda F, D'Amato I et al. Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model. Hum Mol Genet 2012; 21: 5294-5305.
70. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR. Oligodendrocytes and myelination: the role of iron. Glia 2009; 57: 467-478.
71. Smith SR, Cooperman S, Lavaute T, Tresser N, Ghosh M, Meyron-Holtz E et al. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Ann NY Acad Sci 2004; 1012: 65-83.
72. Li J. Molecular regulators of nerve conduction - lessons from inherited neuropathies and rodent genetic models. Exp Neurol 2015; 267: 209-218.
73. Pajevic S, Basser PJ, Fields RD. Role of myelin plasticity in oscillations and synchrony of neuronal activity. Neuroscience 2014; 276: 135-147.
74. Di Paola M, Phillips OR, Sanchez-Castaneda C, Di Pardo A, Maglione V, Caltagirone C et al. MRI measures of corpus callosum iron and myelin in early Huntington's disease. Hum Brain Mapp 2014; 35: 3143-3151.